share_log

Cogent Biosciences | 8-K: Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results

SEC ·  Nov 14, 2022 12:14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 377

Recommended